The Expiry of Humira(®) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
Humira®市场独占权到期及阿达木单抗生物类似药进入欧洲市场：定价及国家政策措施概述
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2020.591134
Moorkens, Evelien; Godman, Brian; Huys, Isabelle; Hoxha, Iris; Malaj, Admir; Keuerleber, Simon; Stockinger, Silvia; Mörtenhuber, Sarah; Dimitrova, Maria; Tachkov, Konstantin; Vončina, Luka; Palčevski, Vera Vlahović; Achniotou, Gnosia; Slabý, Juraj; Popelková, Leona; Kohoutová, Kateřina; Bartels, Dorthe; Laius, Ott; Martikainen, Jaana E; Selke, Gisbert W; Kourafalos, Vasileios; Magnússon, Einar; Einarsdóttir, Rannveig; Adams, Roisín; Joppi, Roberta; Allocati, Eleonora; Jakupi, Arianit; Viksna, Anita; Greičiūtė-Kuprijanov, Ieva; Vella Bonanno, Patricia; Suttorp, Vincent; Melien, Øyvind; Plisko, Robert; Mardare, Ileana; Meshkov, Dmitry; Novakovic, Tanja; Fürst, Jurij; Zara, Corinne; Marković-Peković, Vanda; Grubiša, Nataša; Befrits, Gustaf; Puckett, Robert; Vulto, Arnold G
